Survodutide 10mg

$610

Peptides will arrive in a lyophilized (powder) form for maximum stability.

Survodutide is a dual GLP-1/glucagon receptor agonist peptide supplied as lyophilized powder for laboratory research into incretin and glucagon receptor signaling. HPLC-verified. For research use only — not for human consumption.

In stock

Description

Survodutide (BI 456906) is a synthetic peptide dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors. As a 29-amino-acid acylated GLP-1/glucagon receptor dual-agonist analog, its approximate molecular formula is C192H289N47O61, with a molecular weight of approximately 4232 g/mol.

Research has characterized Survodutide’s binding affinity and downstream signaling at both receptor subtypes, alongside its pharmacokinetic profile in animal and cell-based studies. Investigational endpoints have included hepatic lipid metabolism markers, energy expenditure, and glucose-dependent insulinotropic signaling pathways.

This product is supplied as a lyophilized powder for reconstitution, with each batch verified for identity and purity via HPLC and mass spectrometry.

For laboratory research use only. Not for human or veterinary use, and not approved for any clinical or diagnostic application.